(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3E)-4-(1H-indol-3-yl)but-3-en-2-one is a marine derived natural products found in Tedania (Tedania) ignis.

(3R,4R)-A2-32-01 (compound 2) is a specific caseinolytic protein proteases (ClpP) inhibitor (EC50: 4.5 μM).

(3R,4R)-A2-32-01 (compound 2) is a specific caseinolytic protein proteases (ClpP) inhibitor (EC50: 4.5 μM).

(3R,4R)-A2-32-01 (compound 2) is a specific caseinolytic protein proteases (ClpP) inhibitor (EC50: 4.5 μM).

(3R,4R)-A2-32-01 (compound 2) is a specific caseinolytic protein proteases (ClpP) inhibitor (EC50: 4.5 μM).

(3R,4R)-A2-32-01 (compound 2) is a specific caseinolytic protein proteases (ClpP) inhibitor (EC50: 4.5 μM).

(3R,5R)-1-(4-Hydroxy-3-methoxyphenyl)-7-(3,4-dihydroxyphenyl)heptane-3,5-diol is a natural product for research related to life sciences. The catalog number is TN6389 and the CAS number is 408324-13-0.

(3R,5R)-Rosuvastatin is the (3R,5R)-enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG-CoA reductase inhibitor (IC50: 11 nM).

(3R,5R)-Rosuvastatin is the (3R,5R)-enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG-CoA reductase inhibitor (IC50: 11 nM).

(3R,5R)-Rosuvastatin is the (3R,5R)-enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG-CoA reductase inhibitor (IC50: 11 nM).

(3R,5R)-Rosuvastatin Lactone is an isomer of Rosuvastatin Lactone.

(3R,5S)-Atorvastatin sodium is an impurity of Atorvastatin. Atorvastatin is an HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids.

(3R,5S)-Atorvastatin sodium is an impurity of Atorvastatin. Atorvastatin is an HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids.

(3R)-7,4’-Dihydrohomoisoflavanone, a natural compound, exhibits potent antibacterial properties against both S. aureus and methicillin-resistant Staphylococcus aureus (MRSA).

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one (L(-)-Sorbopyranose) is a ketose belonging to the group of sugars known as monosaccharides.

(3S,4R)-PF-6683324 is a pro-myosin-related kinase (Trk) inhibitor that has shown research potential for pain and cancer (information from patent WO2015092610A1, Example 9).

(3S,4R)-PF-6683324 is a pro-myosin-related kinase (Trk) inhibitor that has shown research potential for pain and cancer (information from patent WO2015092610A1, Example 9).

(3S,4R)-PF-6683324 is a pro-myosin-related kinase (Trk) inhibitor that has shown research potential for pain and cancer (information from patent WO2015092610A1, Example 9).

(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).

(3S,4S)-A2-32-01, a less active (S,S)-enantiomer of A2-32-01. A2-32-01 is a potent caseinolytic protein proteases (ClpP) inhibitor .

(3S, 4S)-PF-06459988 is the less active S enantiomer of PF-06459988, which is a potent irreversible inhibitor of T790M mutant epidermal growth factor receptor (EGFR). PF-06459988 exhibits excellent selectivity against EGFR wild-type due to its minimally reactive electrophile, which reduces the likelihood of off-target labeling.

(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor.